|
|
||||||||
Departments of Anesthesiology and Physiology, Medical College of Wisconsin and Veterans Affairs Medical Center, Milwaukee, Wisconsin 53295
Submitted 28 January 2004 ; accepted in final form 22 February 2004
There is evidence that neuropeptide Y (NPY) acts as a neurotransmitter in vascular smooth muscle and is released with norepinephrine from sympathetic nerves. We hypothesized that NPY Y1 receptor stimulation would produce vasoconstriction in resting and exercising skeletal muscle. Nine mongrel dogs were instrumented chronically with flow probes on the external iliac arteries of both hindlimbs and a catheter in one femoral artery. The selective NPY Y1 receptor agonist [Leu31,Pro34]NPY was infused as a bolus into the femoral artery catheter at rest and during mild, moderate, and heavy exercise. Intra-arterial infusions of [Leu31,Pro34]NPY elicited reductions (P < 0.05) in vascular conductance of 38 ± 3, 25 ± 2, 17 ± 1, and 11 ± 1% at rest, 3 miles/h, 6 miles/h, and 6 miles/h and 10% grade, respectively. The agonist infusions did not affect (P > 0.05) blood flow in the contralateral iliac artery. To examine whether nitric oxide (NO) is responsible for the attenuated vasoconstrictor response during exercise to NPY Y1 receptor stimulation, the infusions were repeated after NO synthase blockade. These infusions yielded reductions (P < 0.05) in vascular conductance of 47 ± 3, 23 ± 2, 19 ± 3, and 12 ± 2% at rest, 3 miles/h, 6 miles/h, and 6 miles/h and 10% grade, respectively. NPY Y1 receptor responsiveness was attenuated (P < 0.05) during exercise compared with rest. Blockade of NO production did not affect (P > 0.05) the attenuation of NPY Y1 receptor responsiveness during exercise. These data support the hypothesis that NPY Y1 receptors can produce vasoconstriction in exercising skeletal muscle.
blood flow; sympatholysis; autonomic nervous system; dogs
This article has been cited by other articles:
![]() |
D. W. Wray, S. K. Nishiyama, A. J. Donato, M. Sander, P. D. Wagner, and R. S. Richardson Endothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humans Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2550 - H2556. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Brothers, M. L. Haslund, D. W. Wray, P. B. Raven, and M. Sander Exercise-induced inhibition of angiotensin II vasoconstriction in human thigh muscle J. Physiol., December 1, 2006; 577(2): 727 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Jonhagen, P Ackermann, T Saartok, P A Renstrom, and P Salo Calcitonin gene related peptide and neuropeptide Y in skeletal muscle after eccentric exercise: a microdialysis study * Commentary. Br. J. Sports Med., March 1, 2006; 40(3): 264 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Buckwalter, J. J. Hamann, and P. S. Clifford Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles J Appl Physiol, December 1, 2005; 99(6): 2115 - 2120. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Jackson, K. J. Milne, E. G. Noble, and J. K. Shoemaker Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats J. Physiol., January 1, 2005; 562(1): 285 - 294. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |